Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Genistein on the Progression of Cognitive Impairment in Patients With Mild Cognitive Impairment: Controlled Clinical Trial

NCT07385937 is registered in ClinicalTrials.gov with Universidad Católica San Antonio de Murcia as lead sponsor.

NCT NCT07385937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07385937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Genistein on the Progression of Cognitive Impairment in Patients With Mild Cognitive Impairment: Controlled Clinical Trial
Lead sponsor
Universidad Católica San Antonio de Murcia
Phase
Not applicable
Overall status
Not yet recruiting
Start date
February 28, 2026
Completion date
December 31, 2027
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease (ad), mild cognitive impairment (mci)